---
stable_id: R-HSA-9665412
display_name: ERBB2 ECD mutants bind TKIs
species: Homo sapiens
summary: Comapred with the wild type ERBB2, ERBB2 G309E, ERBB2 S310F and ERBB2 S310Y
  are more sensitive to tyrosine kinase inhibitors lapatinib, neratinib and afatinib
  (Greulich et al. 2012). ERBB2 G309A was also responsive to  lapatinib and neratinib
  (Bose et al. 2013).
---

# ERBB2 ECD mutants bind TKIs
**Reactome ID:** [R-HSA-9665412](https://reactome.org/content/detail/R-HSA-9665412)
**Species:** Homo sapiens

## Summary

Comapred with the wild type ERBB2, ERBB2 G309E, ERBB2 S310F and ERBB2 S310Y are more sensitive to tyrosine kinase inhibitors lapatinib, neratinib and afatinib (Greulich et al. 2012). ERBB2 G309A was also responsive to  lapatinib and neratinib (Bose et al. 2013).
